Doubts Surface on Safety of Lariam: Malaria Wonder Drug Surface By Paul Redfern Africa News Service The medical profession in the United Kingdom is increasingly concerned over the anti-malarial drug Lariam after new findings show it can cause severe psychotic behavior and epileptic fits. Lariam, manufactured by Hoffmann-La Roche, was to be a wonder drug in the 1990s. Early trials showed it highly effective in protecting against malaria in areas where the parasite that causes the disease was becoming immune to drugs like chloroquine. Initial studies in 1993 said serious side-effects were minimal and that it was over 90 percent effective in protecting from malaria. Now, following further clinical trials, the medical profession is not so sure. Britain's leading expert on the disease, Professor David Bradley from the London School of Hygiene and Tropical Medicine, told the Sunday Times it was now hard to balance the chance of infection from chloroquine-resistant malaria against the risk of drug side effects. "We are really doing sums which have a high degree of uncertainty," Bradley said. "I find it extremely difficult to get the right balance. I do feel very concerned about people who get malaria and people who get side effects." "I have never said any drug was a safe drug...People should balance things carefully and get the best advice they can-and accept that nothing is 100 percent safe." The side effects from Lariam are, medical experts agree, only affecting a minority of users. But the number affected may be as much as one in 140. This has led to hundreds of complaints of serious medical problems from the drug since the early 1990s. Already, 46 Britons have issued writs against Hoffman-La Roche and 150 are in the process of doing so. Another 500 people have contacted their lawyers. The side effects from Lariam are severe and include epileptic attacks, severe depression, hallucination, chronic fatigue and even temporary insanity. When Eric Docker, a 50-year- old detective with the London Metropolitan Police visited Kenya in 1996, he took Lariam while at Treetops, a safari resort. "On the warning leaflet it says don't take Lariam if you suffer from epilepsy, but I don't," Docker said. "I was standing outside the hotel...then I don't remember anything else. "It was a dreadful sight," his wife Sandra said. "Eric collapsed. He was ashen, glazed-looking. I thought he was dying." The hotel doctor, Dr Ajay Chaniyara told the Sunday Times he believed Lariam was the cause and that he had seen at least a dozen similar cases in the past five years. Hoffman-La Roche maintain only a small minority of people taking the drug-around one in 10,000-have severe side effects. The company also says that adequate warnings of possible side effects are put on the packaging for the drug.